Vaccine Development

Vaccine Development

Vaccines are one of the most powerful tools to prevent the spread of infectious disease and bolster global health. Vaccine research and development is often a collaborative effort across private and public sectors, and HJFMRI is a key partner supporting the efforts of governmental and military partners in developing preventive vaccines against some of the world's most pressing infectious disease challenges.

Clinician prepares to administer vaccine

HIV Vaccine Research

HJF has supported the Walter Reed Army Institute of Research U.S. Military HIV Research Program (MHRP) since its inception in 1986. MHRP has emerged as a world leader in HIV vaccine research and development, and HJFMRI has helped MHRP expand these capabilities to multiple sites in Africa.

Learn More

Lassa Fever Consortium

HJFMRI is part of LEAP4WA, a unique multidisciplinary collaboration of seven leading research institutions in Africa, Europe, and North America to advance promising Lassa fever vaccine candidates.

Learn More

COVID-19 Vaccine Efforts

HJFMRI experts and services assist partners in Africa as they conduct research to advance COVID-19 vaccine and monoclonal antibody products. Current efforts support research sites that are part of the COVID-19 Prevention Network (CoVPN).

Learn More

Black man in lab gear looks at computer screen at research laboratory

Developing a Malaria Vaccine

HJFMRI aids the efforts of the Kenya Medical Research Institute/CDC to create a malaria vaccine, even through continuing challenges of the COVID-19 pandemic.

Learn More

Pioneering Ebola Vaccine Research

HJFMRI supported early testing of Ebola vaccine candidates, leveraging its established network of partner clinical research sites in Africa to pivot towards Ebola countermeasures.

Learn More